Senior Vice President of Artificial Intelligence

Senior Vice President, Artificial Intelligence (Immunology) – Confidential Global Biopharma Opportunity

Location: New York, USA

A leading global biopharmaceutical organization is seeking a Senior Vice President of Artificial Intelligence to lead enterprise-level AI strategy across its Immunology and Translational Research portfolio
. This executive will shape next-generation AI-driven discovery, translational science, and experimental data platforms
, enabling accelerated target identification, biomarker discovery, and clinical translation.

• Define and execute the enterprise AI strategy supporting immunology research, translational medicine, and early clinical development.
• Build and lead high-performing multidisciplinary AI, computational biology, and translational data science teams across discovery and clinical functions.
• Drive development of experimental AI frameworks
  , multimodal data integration platforms, and foundation models applied to immunological mechanisms and disease biology.
• Partner closely with R&D, clinical, and external academic/technology collaborators to translate machine learning insights into therapeutic pipelines
  .
• Oversee large-scale biological and clinical data ecosystems
  , ensuring scalable, compliant, and AI-ready data infrastructure.
• Represent the organization externally with key strategic partners, technology alliances, and scientific consortia
  .

• PhD, MD, or equivalent in computational biology, AI/ML, immunology, bioinformatics, or a related quantitative discipline.
• 15+ years of experience spanning AI/ML leadership within large biopharma, advanced biotech, or global technology organizations supporting life sciences
  .
• Demonstrated success applying translational data science, experimental AI, multimodal modeling, or foundation models to therapeutic discovery or clinical development.
• Proven track record building enterprise-scale AI organizations and delivering measurable impact across drug discovery pipelines.
• Strong executive presence with experience advising C-suite and R&D leadership on AI transformation strategy.

• Executive ownership of AI strategy across a major immunology portfolio with global pipeline impact.
• Significant investment commitment in AI-native discovery platforms, multimodal data systems, and translational modeling capabilities
  .
• Opportunity to shape the next generation of AI-enabled therapeutics at global scale.

Apply directly, or reach out to  to discuss further.

#SVPAI, #Chief

AI, #Artificial Intelligence, #Translational Data Science , #Computational Biology, #Immunology

AI, #Experimental

AI, #Machine Learning, #Deep Learning, #Multimodal

AI, #Foundation Models, #Biomedical

AI, #Drug Discovery

AI, #Translational Medicine, #Bioinformatics, #Systems Immunology, #Precision Medicine, #Clinical Data Science , #Biomarker Discovery, #Omics, #Genomics, #Multiomics, #Scientific

AI, #Clinical

AI, #Enterprise

AI, #Life Sciences

AI, #Biopharma

AI, #AI Leadership, #Therapeutic Innovation